Choose Your language:
- Social bookmarks:
- Testimonials
-
Thank you VERY much for your kind email, which explains everything. And
for your continued good service, which has - frankly - saved my
relationship with the woman I love.
Read more »
Our billing is certified by:
- News
-
- FDA approved Tadalafil medication for the treatment of erectile dysfunction accompanied with primary and secondary symptoms of benign prostatic hyperplasia (BPH) in men above 45 years.
- Considering the information of three randomized, multicenter, double, blind clinical studies and a retrospective analysis of the medical documentation, FDA approved on October 7, 2011 Tadalafil medication for the treatment of erectile dysfunction accompanied with primary and secondary symptoms of benign prostatic hyperplasia (BPH) in men above 45 years
- The forming, development and monitoring of the pharmaceutical market in USA in September 2011
- In spite of low rates and stagnation of industrial development, the pharmaceutical market shows a dynamical growth
- Sildenafil citrate and pulmonary arterial hypertension
- Pulmonary arterial hypertension Definition “pulmonary arterial hypertension” is related to a group of diseases characterized by: - Progressive increase in pulmonary vascular resistance; - Reduction in pulmonary bloodflow; - High pulmonary artery pressure; - Contractility of the heart right ventricle; - Right ventricular failure
- Fruit and vegetables do not reduce overall cancer risk, review concludes
- Eating lots of fruit and vegetables will do little to reduce your risk of developing cancer, according to a review of a decade of research involving more than a million people
- Common painkillers could be linked to male reproductive disorder
- The use of mild painkillers, such as paracetamol, in pregnancy – previously considered harmless to the baby in the womb – could be a major factor in the rise of male reproductive disorders, according to a study
-
- Weight-loss therapies improve blood pressure in obese patients - TheHeart.Org
- Weight-loss therapies improve blood pressure in obese patientsTheHeart
- Upsher-Smith Research Shows Unique Pharmacokinetic Profile of USL255 Extended ... - MarketWatch (press release)
- Upsher-Smith Research Shows Unique Pharmacokinetic Profile of USL255 Extended
- ECO: New Weight Loss Drug Effective in Advanced Obesity - Doctors Lounge
- ECO: New Weight Loss Drug Effective in Advanced ObesityDoctors LoungeA new combination treatment of controlled-release phentermine/topiramate leads to significantly greater weight loss than a placebo even in individuals with significant obesity-related comorbidities, according to a study presented at the European
- Drugs to prevent migraines are underused - ConsumerReports.org
- Drugs to prevent migraines are underusedConsumerReports
- New Weight-Loss Drug Shows Promise in Trial - U.S. News & World Report
- USA TODAYNew Weight-Loss Drug Shows Promise in TrialU